Table 1.
Treatment-combination matrix: testing candidate treatments for sleep deficiency in persons with opioid use disorder (OUD). Examples in the table refer to the few relevant published or ongoing clinical studies (see text for discussion).
Primary medications for treating OUD | |||
---|---|---|---|
Sleep intervention | Buprenorphine | Methadone | Naltrexone |
Cognitive-Behavioral | |||
CBTi | [104] | ||
MBTi | |||
Yoga | [107] | ||
Neuromodulation | |||
rTMS | |||
tDCS or tACS | |||
Medications | |||
5-HT2,3 receptor antagonists | [133, 135] | ||
Melatonin1,2 receptor agonists | [129, 131] | ||
Endocannabinoid modulators | |||
Orexin1,2 receptor antagonists | NCT04287062 | NCT04287062, NCT04262193 |
Abbreviations: CBTi, cognitive behavioral treatment for insomnia; MBTi, mindfulness-based therapy for insomnia; rTMS, repetitive transcranial magnetic stimulation; tDCS, transcranial direct current stimulation; tACS, transcranial alternating current stimulation.